HNSCC: Patients who received Met before surgery had enhanced tumor infiltration of NK cells, which inhibited the CXCL1 pathway, while stimulating the STAT1 pathway within HNSCC NK cells, which enhanced NK cytotoxicity and prolonged overall survival when combined with chemoradiotherapy. The gene discussed is STAT1; the disease is head and neck squamous cell carcinoma.